2018 BFC BD and Investment Conference

BFC Global Healthcare Investment Conference

BFC医疗健康国际商务合作投资研讨会

January 7, 2018

The St. Regis San Francisco, 125 3rd Street San Francisco, California 94103

旧金山瑞吉酒店

You are invited to attend the BFC 2018 Global Healthcare Business Development and Investment Conference taking place on January 7 at The St. Regis San Francisco (http://www.starwoodhotels.com/stregis/property/overview/index.htmlpropertyID=1511). The conference will highlight key trends in the following areas: 

• Biotech capital market trends in both the US and China

• Out-licensing, the emerging trend among Chinese biotech companies

• Key success factors for Nasdaq listing of a Chinese biotech company

• Leading biotech company presentations 

Senior executives from more than 100 public & private healthcare companies across the biopharmaceuticals, IVD, medical device, and healthcare services sectors will attend this event. More than 100 PE and VC investors from over 100 firms will also attend.

The conference will provide an optimal environment for networking with the senior executives of your potential partners. Company management teams and investors will also have the opportunity to participate in one-on-one and small group meetings through BFC Group.

Agenda:

8:00 – 9:00 Registration

9:00 – 9:15 Opening Remark

• Speaker: David Chen, Managing Director, BFC Group

9:15 – 10:15 State of Healthcare Investment in China and US

• Moderator: David Wang, Managing Partner, OrbiMed Asia
• Panelists:
  • Min Fang, Managing Director, Warburg Pinkus
  • Lu Huang, Morningside Venture
  • Lilly Han, Partner, Sunshine Insurance
  • Jack Yin, Executive Director, SDIC Fund
  • Jin Wan, Executive Director, SDIC Venture Capital

10:00 – 11:00 Road to a Successful US IPO in the Current Market Environment

• Moderator: Charlie Kim
• Panelists:
  • Katherine Xu, Partner and Co-Head of the Biopharmaceutical Equity Research Group, William Blair
  • John Whittaker, Executive Director, J.P. Morgan Investment Bank, Equity Capital Markets, J.P. Morgan Chase & Co.
  • David Ke, Vice President at J.P. Morgan Investment Bank, Equity Capital Markets, J.P. Morgan Chase & Co.
  • Lili Zheng, Managing Partner, Deloitte

11:00 – 11:30  Tea Break

11:30 – 12:30 Selling to the West – Seeking Out-licensing Opportunities to Major Biopharma Companies in the West

• Moderator: Christina Zhang, Partner and Chief Representative of Shanghai Office, Cooley
• Speaker:
  • Vice President, Corporate Development at Gilead Sciences (Invited)
  • VP of Business Development, AbbVie (Invited)
  • VP of Business Development, Celgene (Invited)
  • Syed Kazmi, Executive Director of Business Development, Amgen (Invited)
  • Barbara Kosacz, Partner, Cooley 

12:30 – 14:00 Lunch Break

14:00 – 15:30 Mini Company Road Show

•             Moderator: Kevin Chen, Partner, Founding Partner, Biotrack Capital

15:30 – 16:00 Tea Break

16: 00 – 17:00  Searching for the Dream Deals in US and China

• Moderator: Ben Qiu, Partner, Advantech
• Panelists:
  • Fei Chen, Partner, Lilly Asia Ventures
  • Partner, YF Capital
  • Partner, Beta Pharma
  • Chief Business Officer, Biontech (Germany)
  • Leading biotech company in US

17: 00 – 18:00  Wine Reception

For questions, please email: conference@bfcgroup.biz

With kindest regards,

Organizing Committee, BFC Healthcare Business Development and Investment Conference